There are now countless incredible examples of how artificial intelligence (AI) is transforming patient care to predict and ...

Johnson & Johnson (J&J) has announced it has entered into a definitive agreement with Numab Therapeutics to acquire its ...

Novartis has shared positive results from a late-stage trial of its factor B inhibitor Fabhalta (iptacopan) in patients with ...

On the Global Health Beat, Matthew Durham, our Director of Global Media; Juan Pedro Franco, General Director, Fidia ...

Going beyond the sales rep to NPP channels is becoming critical in Europe, as this new PM360 article by our Director of ...

GSK has shared positive headline results from two late-stage studies of its “ultra-long-acting” biologic, depemokimab, in patients with severe asthma. The phase 3 SWIFT-1 and SWIFT-2 trials have been ...

Eli Lilly has announced that it will be investing an additional $5.3bn in its two new US manufacturing sites, bringing the total spend up to $9bn and making it the largest manufacturing investment in ...

Eli Lilly has entered into a strategic multi-target discovery collaboration agreement with Aktis Oncology in a deal worth more than $1bn to develop novel anticancer radiopharmaceuticals. The ...

Medscape Education is bringing its public health efforts to Washington, DC for the SYNC conference on HIV, HCV, STIs, Harm Reduction, and LGBTQ health. During the conference, Lindsey will present a ...

Merck KGaA has announced it has signed a definitive agreement to acquire Mirus Bio in a deal worth $600m, which will complement its current portfolio of novel modalities. Anticipated to close in the ...

Amgen’s Imdelltra (tarlatamab-dlle) has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat extensive-stage small cell lung cancer (SCLC). The immunotherapy has ...

If you have some years’ experience as a marketing strategist, you will have noticed an interesting evolutionary phenomenon in how our industry strategises. Many species of management ideas have risen ...